Updated analysis of CALGB 100104: lenalidomide (Len) vs. placebo maintenance therapy after single autologous stem cell transplant (ASCT) for multiple myeloma (MM).
- Citation:
- J Clin Oncol vol 33 (suppl) abstr 8523
- Meeting Instance:
- ASCO 2015
- Year:
- 2015
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Long-Term-Followup
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2660
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, CA31946, CA33601
- Corr. Author:
- Authors:
- Sarah A. Holstein Kouros Owzar Paul G. Richardson Chen Jiang Craig C. Hofmeister Hani Hassoun David D. Hurd Edward A. Stadtmauer Sergio Giralt Steven M. Devine Vera Hars John Postiglione Daniel J. Weisdorf Ravi Vij Jan S. Moreb Natalie S. Callander Marcelo C. Pasquini Thomas C. Shea Kenneth Anderson Philip L. McCarthy
- Networks:
- LAPS-MA036, LAPS-MO011, LAPS-NC007, LAPS-NY016, LAPS-NY158, LAPS-OH007, LAPS-WI013, LAPS-WI020, MN022, NC002, NE003, SCOR
- Study
- CALGB-100104
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: